Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Charles Bowden
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Concepts & Ideas
Procedures
Devices
Sign-in to see full Profile
Network (preview)
49
Calabrese, Joseph
22
Swann, Alan
20
Katz, Martin
17
Javors, Martin
13
Ketter, Terence
13
Frazer, Alan
12
Thase, Michael
12
Suppes, Trisha
12
Tohen, Mauricio
11
Vieta, Eduard
11
Soares, Jair
11
Sachs, Gary
11
Miklowitz, David
9
Petty, Frederick
9
Hatch, John
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Charles Bowden (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Bowden Charles L
Diagnosis and impact of bipolar depression.
The Journal of clinical psychiatry 2009;70(9):e32.
-
2009: Matsuo Koji; Nicoletti Mark A; Peluso Marco A M; Hatch John P; Nemoto Kiyotaka; Watanabe Yoshifumi; Nery Fabiano G; Monkul E Serap; Zunta-Soares Giovana B; Bowden Charles L; Soares Jair C
Anterior cingulate volumes associated with trait impulsivity in individuals with bipolar disorder.
Bipolar disorders 2009;11(6):628-36.
-
2009: Tohen Mauricio; Frank Ellen; Bowden Charles L; Colom Francesc; Ghaemi S Nassir; Yatham Lakshmi N; Malhi Gin S; Calabrese Joseph R; Nolen Willem A; Vieta Eduard; Kapczinski Flávio; Goodwin Guy M; Suppes Trisha; Sachs Gary S; Chengappa Kn Roy; Grunze Heinz; Mitchell Philip B; Kanba Shigenobu; Berk Michael
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.
Bipolar disorders 2009;11(5):453-73.
-
2009: Matsuo Koji; Walss-Bass Consuelo; Nery Fabiano G; Nicoletti Mark A; Hatch John P; Frey Benicio N; Monkul Emel S; Zunta-Soares Giovana B; Bowden Charles L; Escamilla Michael A; Soares Jair C
Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(8):1904-13.
-
2009: Frye M A; Yatham L; Ketter T A; Goldberg J; Suppes T; Calabrese J R; Bowden C L; Bourne E; Bahn R S; Adams B
Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies.
Acta psychiatrica Scandinavica 2009;120(1):10-3.
-
2009: Tohen Mauricio; Sutton Virginia K; Calabrese Joseph R; Sachs Gary S; Bowden Charles L
Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder.
Journal of affective disorders 2009;116(1-2):43-50.
-
2009: Bowden Charles L
Anticonvulsants in bipolar disorders: current research and practice and future directions.
Bipolar disorders 2009;11 Suppl 2():20-33.
-
2009: Perlis Roy H; Dennehy Ellen B; Miklowitz David J; Delbello Melissa P; Ostacher Michael; Calabrese Joseph R; Ametrano Rebecca M; Wisniewski Stephen R; Bowden Charles L; Thase Michael E; Nierenberg Andrew A; Sachs Gary
Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study.
Bipolar disorders 2009;11(4):391-400.
-
2009: Severus W E; Kleindienst N; Evoniuk G; Bowden C; Möller H J; Bohus M; Frangou S; Greil W; Calabrese J R
Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
Journal of affective disorders 2009;115(3):466-70.
-
2009: Goldberg Joseph F; Perlis Roy H; Bowden Charles L; Thase Michael E; Miklowitz David J; Marangell Lauren B; Calabrese Joseph R; Nierenberg Andrew A; Sachs Gary S
Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD.
The American journal of psychiatry 2009;166(2):173-81.
-
2009: Grunze Heinz; Vieta Eduard; Goodwin Guy M; Bowden Charles; Licht Rasmus W; Moller Hans-Jurgen; Kasper Siegfried
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(2):85-116.
-
2008: Tohen Mauricio; Vieta Eduard; Goodwin Guy M; Sun Bin; Amsterdam Jay D; Banov Michael; Shekhar Anantha; Aaronson Scott T; Bardenstein Leonid; Grecu-Gabos Iosif; Tochilov Vladimir; Prelipceanu Dan; Oliff Heather S; Kryzhanovskaya Ludmila; Bowden Charles
Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.
The Journal of clinical psychiatry 2008;69(11):1776-89.
-
2008: Bowden Charles L
Bipolar pathophysiology and development of improved treatments.
Brain research 2008;1235():92-7.
-
2008: Bowden Charles; Gögüs Ahmet; Grunze Heinz; Häggström Lars; Rybakowski Janusz; Vieta Eduard
A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
International clinical psychopharmacology 2008;23(5):254-62.
-
2008: Goodwin Guy M; Anderson Ian; Arango Celso; Bowden Charles L; Henry Chantal; Mitchell Philip B; Nolen Willem A; Vieta Eduard; Wittchen Hans-Ulrich
ECNP consensus meeting. Bipolar depression. Nice, March 2007.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008;18(7):535-49.
-
2008: Nery Fabiano G; Hatch John P; Glahn David C; Nicoletti Mark A; Monkul E Serap; Najt Pablo; Fonseca Manoela; Bowden Charles L; Cloninger C Robert; Soares Jair C
Temperament and character traits in patients with bipolar disorder and associations with comorbid alcoholism or anxiety disorders.
Journal of psychiatric research 2008;42(7):569-77.
-
2008: Weisler Richard H; Calabrese Joseph R; Bowden Charles L; Ascher John A; DeVeaugh-Geiss Joseph; Evoniuk Gary
Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence.
Journal of affective disorders 2008;108(1-2):1-9.
-
2008: McElroy Susan L; Bowden Charles L; Collins Michelle A; Wozniak Patricia J; Keck Paul E; Calabrese Joseph R
Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder.
Journal of affective disorders 2008;107(1-3):127-33.
-
2008: Nery Fabiano G; Monkul Emel S; Hatch John P; Fonseca Manoela; Zunta-Soares Giovana B; Frey Benício N; Bowden Charles L; Soares Jair C
Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.
Human psychopharmacology 2008;23(2):87-94.
-
2008: Tohen Mauricio; Bowden Charles L; Smulevich Anatoly B; Bergstrom Richard; Quinlan Tonya; Osuntokun Olawale; Wang Wei V; Oliff Heather S; Martenyi Ferenc; Kryzhanovskaya Ludmila A; Greil Waldemar
Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes.
The British journal of psychiatry : the journal of mental science 2008;192(2):135-43.
-
2008: Davis Lori L; Davidson Jonathan R T; Ward L Charles; Bartolucci Al; Bowden Charles L; Petty Frederick
Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population.
Journal of clinical psychopharmacology 2008;28(1):84-8.
-
2008: Thase Michael E; Jonas Alan; Khan Arif; Bowden Charles L; Wu Xiaoling; McQuade Robert D; Carson William H; Marcus Ronald N; Owen Randall
Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
Journal of clinical psychopharmacology 2008;28(1):13-20.
-
2008: Bowden Charles L; Edwards Suzanne; Evoniuk Gary
Open-label, concomitant use of lamotrigine and other medications for bipolar disorder.
CNS spectrums 2008;13(1):75-83.
-
2008: Goldberg Joseph F; Bowden Charles L; Calabrese Joseph R; Ketter Terence A; Dann Rebekkah S; Frye Mark A; Suppes Trisha; Post Robert M
Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder.
Biological psychiatry 2008;63(1):125-30.
-
2008: Gonzalez Jodi M; Bowden Charles L; Katz Martin M; Thompson Peter; Singh Vivek; Prihoda Thomas J; Dahl Martha
Development of the Bipolar Inventory of Symptoms Scale: concurrent validity, discriminant validity and retest reliability.
International journal of methods in psychiatric research 2008;17(4):198-209.
-
2007: Tohen Mauricio; Calabrese Joseph; Vieta Eduard; Bowden Charles; Gonzalez-Pinto Ana; Lin Daniel; Xu Wen; Corya Sara
Effect of comorbid anxiety on treatment response in bipolar depression.
Journal of affective disorders 2007;104(1-3):137-46.
-
2007: Frey Benicio N; Walss-Bass Consuelo; Stanley Jeffrey A; Nery Fabiano G; Matsuo Koji; Nicoletti Mark A; Hatch John P; Bowden Charles L; Escamilla Michael A; Soares Jair C
Brain-derived neurotrophic factor val66met polymorphism affects prefrontal energy metabolism in bipolar disorder.
Neuroreport 2007;18(15):1567-70.
-
2007: Glahn David C; Bearden Carrie E; Barguil Marcela; Barrett Jennifer; Reichenberg Abraham; Bowden Charles L; Soares Jair C; Velligan Dawn I
The neurocognitive signature of psychotic bipolar disorder.
Biological psychiatry 2007;62(8):910-6.
-
2007: Houston John P; Lipkovich Ilya A; Ahl Jonna; Rotelli Matthew D; Baker Robert W; Bowden Charles L
Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: post hoc analysis of patients treated with olanzapine or lithium.
Journal of psychiatric research 2007;41(7):616-21.
-
2007: Goldberg Joseph F; Perlis Roy H; Ghaemi S Nassir; Calabrese Joseph R; Bowden Charles L; Wisniewski Stephen; Miklowitz David J; Sachs Gary S; Thase Michael E
Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.
The American journal of psychiatry 2007;164(9):1348-55.
-
2007: Bowden C L; Singh V; Thompson P; Gonzalez J M; Katz M M; Dahl M; Prihoda T J; Chang X
Development of the bipolar inventory of symptoms scale.
Acta psychiatrica Scandinavica 2007;116(3):189-94.
-
2007: Peluso M A M; Hatch J P; Glahn D C; Monkul E S; Sanches M; Najt P; Bowden C L; Barratt E S; Soares J C
Trait impulsivity in patients with mood disorders.
Journal of affective disorders 2007;100(1-3):227-31.
-
2007: Sachs Gary S; Nierenberg Andrew A; Calabrese Joseph R; Marangell Lauren B; Wisniewski Stephen R; Gyulai Laszlo; Friedman Edward S; Bowden Charles L; Fossey Mark D; Ostacher Michael J; Ketter Terence A; Patel Jayendra; Hauser Peter; Rapport Daniel; Martinez James M; Allen Michael H; Miklowitz David J; Otto Michael W; Dennehy Ellen B; Thase Michael E
Effectiveness of adjunctive antidepressant treatment for bipolar depression.
The New England journal of medicine 2007;356(17):1711-22.
-
2007: Gonzalez Jodi M; Perlick Deborah A; Miklowitz David J; Kaczynski Richard; Hernandez Melissa; Rosenheck Robert A; Culver Jenifer L; Ostacher Michael J; Bowden Charles L;
Factors associated with stigma among caregivers of patients with bipolar disorder in the STEP-BD study.
Psychiatric services (Washington, D.C.) 2007;58(1):41-8.
-
2007: Bowden Charles L
Spectrum of effectiveness of valproate in neuropsychiatry.
Expert review of neurotherapeutics 2007;7(1):9-16.
-
2007: Gonzalez Jodi M; Thompson Peter; Escamilla Michael; Araga Mako; Singh Vivek; Farrelly Niamh; Thase Michael E; Miklowitz David J; Bowden Charles L
Treatment characteristics and illness burden among European Americans, African Americans, and Latinos in the first 2,000 patients of the systematic treatment enhancement program for bipolar disorder.
Psychopharmacology bulletin 2007;40(1):31-46.
-
2006: Redmond James R; Jamison Katrina L; Bowden Charles L
Lamotrigine combined with divalproex or lithium for bipolar disorder: a case series.
CNS spectrums 2006;11(12):915-8.
-
2006: Tohen Mauricio; Bowden Charles L; Calabrese Joseph R; Lin Daniel; Forrester Tammy D; Sachs Gary S; Koukopoulos Athanasios; Yatham Lakshmi; Grunze Heinz
Influence of sub-syndromal symptoms after remission from manic or mixed episodes.
The British journal of psychiatry : the journal of mental science 2006;189():515-9.
-
2006: Katz Martin M; Bowden Charles L; Berman Nancy; Frazer Alan
Resolving the onset of antidepressants' clinical actions: critical for clinical practice and new drug development.
Journal of clinical psychopharmacology 2006;26(6):549-53.
-
2006: Frye Mark A; Yatham Lakshmi N; Calabrese Joseph R; Bowden Charles L; Ketter Terence A; Suppes Trisha; Adams Bryan E; Thompson Thomas R
Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials.
The Journal of clinical psychiatry 2006;67(11):1721-8.
-
2006: Bowden Charles L; Swann Alan C; Calabrese Joseph R; Rubenfaer Leon M; Wozniak Patricia J; Collins Michelle A; Abi-Saab Walid; Saltarelli Mario;
A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania.
The Journal of clinical psychiatry 2006;67(10):1501-10.
-
2006: Bowden Charles L; Calabrese Joseph R; Ketter Terence A; Sachs Gary S; White Robin L; Thompson Thomas R
Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder.
The American journal of psychiatry 2006;163(7):1199-201.
-
2006: Bowden Charles; Singh Vivek
Bipolar disorders: treatment options and patient satisfaction.
Neuropsychiatric disease and treatment 2006;2(2):149-53.
-
2006: Katz M M; Frazer A; Bowden C L
'Delay' hypothesis of onset of antidepressant action.
The British journal of psychiatry : the journal of mental science 2006;188():586; author reply 587.
-
2006: Glahn David C; Bearden Carrie E; Bowden Charles L; Soares Jair C
Reduced educational attainment in bipolar disorder.
Journal of affective disorders 2006;92(2-3):309-12.
-
2006: Katz Martin M; Houston John P; Brannan Stephen; Tekell Janet; Berman Nancy; Bowden Charles L; Frazer Alan
A video method for the evaluation of antidepressant clinical and behavioural actions.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2006;9(3):327-36.
-
2006: Bowden Charles L; Karren Nancy U
Anticonvulsants in bipolar disorder.
The Australian and New Zealand journal of psychiatry 2006;40(5):386-93.
-
2006: Sachs Gary; Bowden Charles; Calabrese Joseph R; Ketter Terence; Thompson Thomas; White Robin; Bentley Beth
Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder.
Bipolar disorders 2006;8(2):175-81.
-
2006: Caetano Sheila C; Olvera Rene L; Hunter Kristina; Hatch John P; Najt Pablo; Bowden Charles; Pliszka Steven; Soares Jair C
Association of psychosis with suicidality in pediatric bipolar I, II and bipolar NOS patients.
Journal of affective disorders 2006;91(1):33-7.
-
2006: Allen Michael H; Hirschfeld Robert M; Wozniak Patricia J; Baker Jeffrey D; Bowden Charles L
Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania.
The American journal of psychiatry 2006;163(2):272-5.
-
2006: Tohen Mauricio; Calabrese Joseph R; Sachs Gary S; Banov Michael D; Detke Holland C; Risser Richard; Baker Robert W; Chou James C-Y; Bowden Charles L
Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
The American journal of psychiatry 2006;163(2):247-56.
-
2006: Bowden Charles L
Cognitive therapy is more cost effective than standard care alone for bipolar disorder.
Evidence-based mental health 2006;9(1):14.
-
2006: Bearden Carrie E; Glahn David C; Monkul E Serap; Barrett Jennifer; Najt Pablo; Kaur Simerjit; Sanches Marsal; Villarreal Veronica; Bowden Charles; Soares Jair C
Sources of declarative memory impairment in bipolar disorder: mnemonic processes and clinical features.
Journal of psychiatric research 2006;40(1):47-58.
-
2005: Allen Michael H; Chessick Cheryl A; Miklowitz David J; Goldberg Joseph F; Wisniewski Stephen R; Miyahara Sachiko; Calabrese Joseph R; Marangell Lauren; Bauer Mark S; Thomas Marshall R; Bowden Charles L; Sachs Gary S
Contributors to suicidal ideation among bipolar patients with and without a history of suicide attempts.
Suicide & life-threatening behavior 2005;35(6):671-80.
-
2005: Bowden Charles L; Ketter Terence A; Sachs Gary S; Thase Michael E
Focus on bipolar disorder treatment.
The Journal of clinical psychiatry 2005;66(12):1598-609.
-
2005: Goldberg Joseph F; Allen Michael H; Miklowitz David A; Bowden Charles L; Endick Carrie J; Chessick Cheryl A; Wisniewski Stephen R; Miyahara Sachiko; Sagduyu Kemal; Thase Michael E; Calabrese Joseph R; Sachs Gary S
Suicidal ideation and pharmacotherapy among STEP-BD patients.
Psychiatric services (Washington, D.C.) 2005;56(12):1534-40.
-
2005: Bowden Charles L; Collins Michelle A; McElroy Susan L; Calabrese Joseph R; Swann Alan C; Weisler Richard H; Wozniak Patricia J
Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(10):1932-9.
-
2005: Suppes Trisha; Dennehy Ellen B; Hirschfeld Robert M A; Altshuler Lori L; Bowden Charles L; Calabrese Joseph R; Crismon M Lynn; Ketter Terence A; Sachs Gary S; Swann Alan C;
The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.
The Journal of clinical psychiatry 2005;66(7):870-86.
-
2005: Tohen Mauricio; Greil Waldemar; Calabrese Joseph R; Sachs Gary S; Yatham Lakshmi N; Oerlinghausen Bruno Müller; Koukopoulos Athanasios; Cassano Giovanni B; Grunze Heinz; Licht Rasmus W; Dell'Osso Liliana; Evans Angela R; Risser Richard; Baker Robert W; Crane Heidi; Dossenbach Martin R; Bowden Charles L
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
The American journal of psychiatry 2005;162(7):1281-90.
-
2005: Bowden Charles L
Bipolar disorder and work loss.
The American journal of managed care 2005;11(3 Suppl):S91-4.
-
2005: Weiss Roger D; Ostacher Michael J; Otto Michael W; Calabrese Joseph R; Fossey Mark; Wisniewski Stephen R; Bowden Charles L; Nierenberg Andrew A; Pollack Mark H; Salloum Ihsan M; Simon Naomi M; Thase Michael E; Sachs Gary S;
Does recovery from substance use disorder matter in patients with bipolar disorder?
The Journal of clinical psychiatry 2005;66(6):730-5; quiz 808-9.
-
2005: Najt Pablo; Glahn David; Bearden Carrie E; Hatch John P; Monkul E Serap; Kaur Simerjit; Villarreal Veronica; Bowden Charles; Soares Jair C
Attention deficits in bipolar disorder: a comparison based on the Continuous Performance Test.
Neuroscience letters 2005;379(2):122-6.
-
2005: Bowden Charles L
A different depression: clinical distinctions between bipolar and unipolar depression.
Journal of affective disorders 2005;84(2-3):117-25.
-
2005: Bowden Charles L; Grunze Heinz; Mullen Jamie; Brecher Martin; Paulsson Björn; Jones Martin; Vågerö Mårten; Svensson K
A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.
The Journal of clinical psychiatry 2005;66(1):111-21.
-
2005: Mansour Hader A; Talkowski Michael E; Wood Joel; Pless Lora; Bamne Mikhil; Chowdari Kodavali V; Allen Michael; Bowden Charles L; Calabrese Joseph; El-Mallakh Rif S; Fagiolini Andrea; Faraone Stephen V; Fossey Mark D; Friedman Edward S; Gyulai Laszlo; Hauser Peter; Ketter Terence A; Loftis Jennifer M; Marangell Lauren B; Miklowitz David J; Nierenberg Andrew A; Patel Jayendra; Sachs Gary S; Sklar Pamela; Smoller Jordan W; Thase Michael E; Frank Ellen; Kupfer David J; Nimgaonkar Vishwajit L
Serotonin gene polymorphisms and bipolar I disorder: focus on the serotonin transporter.
Annals of medicine 2005;37(8):590-602.
-
2005: Yatham Lakshmi N; Goldstein Jeffrey M; Vieta Eduard; Bowden Charles L; Grunze Heinz; Post Robert M; Suppes Trisha; Calabrese Joseph R
Atypical antipsychotics in bipolar depression: potential mechanisms of action.
The Journal of clinical psychiatry 2005;66 Suppl 5():40-8.
-
2005: Bowden Charles L
Introduction: the burden of bipolar depression.
The Journal of clinical psychiatry 2005;66 Suppl 5():3-4.
-
2005: Calabrese Joseph R; Keck Paul E; Bowden Charles L; Ketter Terence A; Sachs Gary; Findling Robert L; Sajatovic Martha
A US perspective of the CANMAT bipolar guidelines.
Bipolar disorders 2005;7 Suppl 3():70-2.
-
2005: Bowden C L; Singh V
Valproate in bipolar disorder: 2000 onwards.
Acta psychiatrica Scandinavica. Supplementum 2005;(426):13-20.
-
2005: Bowden Charles L
Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.
The Journal of clinical psychiatry 2005;66 Suppl 3():12-9.
-
2005: Bowden Charles L
Treatment options for bipolar depression.
The Journal of clinical psychiatry 2005;66 Suppl 1():3-6.
-
2004: Bowden Charles L
Relationship of acute mania symptomatology to maintenance treatment response.
Current psychiatry reports 2004;6(6):473-7.
-
2004: Katz Martin M; Houston John P; Brannan Steven; Bowden Charles L; Berman Nancy; Swann Alan C; Frazer Alan
A multivantaged behavioural method for measuring onset and sequence of the clinical actions of antidepressants.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2004;7(4):471-9.
-
2004: O'Brien Charles P; Charney Dennis S; Lewis Lydia; Cornish James W; Post Robert M; Woody George E; Zubieta Jon-Kar; Anthony James C; Blaine Jack D; Bowden Charles L; Calabrese Joseph R; Carroll Kathleen; Kosten Thomas; Rounsaville Bruce; Childress Anna Rose; Oslin David W; Pettinati Helen M; Davis Mark A; Demartino Robert; Drake Robert E; Fleming Michael F; Fricks Larry; Glassman Alexander H; Levin Frances R; Nunes Edward V; Johnson Robert L; Jordan Clarence; Kessler Ronald C; Laden Sally K; Regier Darrel A; Renner John A; Ries Richard K; Sklar-Blake Thomas; Weisner Constance
Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action.
Biological psychiatry 2004;56(10):703-13.
-
2004: Schneck Christopher D; Miklowitz David J; Calabrese Joseph R; Allen Michael H; Thomas Marshall R; Wisniewski Stephen R; Miyahara Sachiko; Shelton Melvin D; Ketter Terence A; Goldberg Joseph F; Bowden Charles L; Sachs Gary S
Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program.
The American journal of psychiatry 2004;161(10):1902-8.
-
2004: Grunze Heinz; Kasper Siegfried; Goodwin Guy; Bowden Charles; Möller Hans-Jürgen;
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2004;5(3):120-35.
-
2004: Bowden Charles L; Myers Joyce E; Grossman Fred; Xie Yang
Risperidone in combination with mood stabilizers: a 10-week continuation phase study in bipolar I disorder.
The Journal of clinical psychiatry 2004;65(5):707-14.
-
2004: Bowden Charles L; Krishnan Anupama A
Pharmacotherapy for bipolar depression: an economic assessment.
Expert opinion on pharmacotherapy 2004;5(5):1101-7.
-
2004: Perlis Roy H; Miyahara Sachiko; Marangell Lauren B; Wisniewski Stephen R; Ostacher Michael; DelBello Melissa P; Bowden Charles L; Sachs Gary S; Nierenberg Andrew A;
Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD).
Biological psychiatry 2004;55(9):875-81.
-
2004: Bowden C
The effectiveness of divalproate in all forms of mania and the broader bipolar spectrum: many questions, few answers.
Journal of affective disorders 2004;79 Suppl 1():S9-14.
-
2004: Tohen Mauricio; Chengappa K N Roy; Suppes Trisha; Baker Robert W; Zarate Carlos A; Bowden Charles L; Sachs Gary S; Kupfer David J; Ghaemi S Nassir; Feldman Peter D; Risser Richard C; Evans Angela R; Calabrese Joseph R
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.
The British journal of psychiatry : the journal of mental science 2004;184():337-45.
-
2004: Marangell Lauren B; Martinez James M; Ketter Terence A; Bowden Charles L; Goldberg Joseph F; Calabrese Joseph R; Miyahara Sachiko; Miklowitz David J; Sachs Gary S; Thase Michael E;
Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD.
Bipolar disorders 2004;6(2):139-43.
-
2004: Goodwin Guy M; Bowden Charles L; Calabrese Joseph R; Grunze Heinz; Kasper Siegfried; White Robin; Greene Paul; Leadbetter Robert
A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.
The Journal of clinical psychiatry 2004;65(3):432-41.
-
2004: Katz Martin M; Tekell Janet L; Bowden Charles L; Brannan Steve; Houston John P; Berman Nancy; Frazer Alan
Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(3):566-79.
-
2004: Bowden Charles; Fawcett Jan
Pharmacotherapy and risk of suicidal behaviors among patients with bipolar disorder.
JAMA : the journal of the American Medical Association 2004;291(8):939; author reply 940.
-
2004: Bowden Charles L
Making optimal use of combination pharmacotherapy in bipolar disorder.
The Journal of clinical psychiatry 2004;65 Suppl 15():21-4.
-
2004: Bowden Charles L
Introduction: managing bipolar depression.
The Journal of clinical psychiatry 2004;65 Suppl 10():3-4.
-
2004: Bowden Charles L; Asnis Gregory M; Ginsberg Lawrence D; Bentley Beth; Leadbetter Robert; White Robin
Safety and tolerability of lamotrigine for bipolar disorder.
Drug safety : an international journal of medical toxicology and drug experience 2004;27(3):173-84.
-
2003: Tohen Mauricio; Vieta Eduard; Calabrese Joseph; Ketter Terence A; Sachs Gary; Bowden Charles; Mitchell Philip B; Centorrino Franca; Risser Richard; Baker Robert W; Evans Angela R; Beymer Karin; Dube Sanjay; Tollefson Gary D; Breier Alan
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
Archives of general psychiatry 2003;60(11):1079-88.
-
2003: Calabrese Joseph R; Bowden Charles L; Sachs Gary; Yatham Lakshmi N; Behnke Kirsten; Mehtonen Olli-Pekka; Montgomery Paul; Ascher John; Paska Walter; Earl Nancy; DeVeaugh-Geiss Joseph;
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
The Journal of clinical psychiatry 2003;64(9):1013-24.
-
2003: Bowden Charles L
Acute and maintenance treatment with mood stabilizers.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2003;6(3):269-75.
-
2003: Gyulai Laszlo; Bowden Charles L; McElroy Susan L; Calabrese Joseph R; Petty Frederick; Swann Alan C; Chou James C-Y; Wassef Adel; Risch Craig S; Hirschfeld Robert M A; Nemeroff Charles B; Keck Paul E; Evans Dwight L; Wozniak Patricia J
Maintenance efficacy of divalproex in the prevention of bipolar depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(7):1374-82.
-
2003: Sachs Gary S; Thase Michael E; Otto Michael W; Bauer Mark; Miklowitz David; Wisniewski Stephen R; Lavori Philip; Lebowitz Barry; Rudorfer Mathew; Frank Ellen; Nierenberg Andrew A; Fava Maurizio; Bowden Charles; Ketter Terence; Marangell Lauren; Calabrese Joseph; Kupfer David; Rosenbaum Jerrold F
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).
Biological psychiatry 2003;53(11):1028-42.
-
2003: Bowden Charles L
Valproate.
Bipolar disorders 2003;5(3):189-202.
-
2003: Johnson Bankole A; Ait-Daoud Nassima; Bowden Charles L; DiClemente Carlo C; Roache John D; Lawson Kevin; Javors Martin A; Ma Jennie Z
Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.
Lancet 2003;361(9370):1677-85.
-
2003: Bowden Charles L; Calabrese Joseph R; Sachs Gary; Yatham Lakshmi N; Asghar Shaheen Akthar; Hompland Magne; Montgomery Paul; Earl Nancy; Smoot Tonya M; DeVeaugh-Geiss Joseph;
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
Archives of general psychiatry 2003;60(4):392-400.
-
2003: Bowden Charles L
Improving identification of treatment effectiveness in bipolar disorders.
Bipolar disorders 2003;5(2):77-8.
-
2003: Grunze Heinz; Kasper Siegfried; Goodwin Guy; Bowden Charles; Baldwin David; Licht Rasmus W; Vieta Eduard; Möller Hans-Jürgen;
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2003;4(1):5-13.
-
2003: Sanger Todd M; Tohen Mauricio; Vieta Eduard; Dunner David L; Bowden Charles L; Calabrese Joseph R; Feldman Peter D; Jacobs Thomas G; Breier Alan
Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling.
Journal of affective disorders 2003;73(1-2):155-61.
-
2002: Calabrese Joseph R; Sullivan John R; Bowden Charles L; Suppes Trisha; Goldberg Joseph F; Sachs Gary S; Shelton Melvin D; Goodwin Frederick K; Frye Mark A; Kusumakar Vivek
Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management.
The Journal of clinical psychiatry 2002;63(11):1012-9.
-
2002: Bowden Charles L
Lamotrigine in the treatment of bipolar disorder.
Expert opinion on pharmacotherapy 2002;3(10):1513-9.
-
2002: Wagner Karen Dineen; Weller Elizabeth B; Carlson Gabrielle A; Sachs Gary; Biederman Joseph; Frazier Jean A; Wozniak Patricia; Tracy Katherine; Weller Ronald A; Bowden Charles
An open-label trial of divalproex in children and adolescents with bipolar disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 2002;41(10):1224-30.
-
2002: Katz Martin M; Halbreich Uriel M; Bowden Charles L; Frazer Alan; Pinder Roger M; Rush A John; Wheatley David P; Lebowitz Barry D
Enhancing the technology of clinical trials and the trials model to evaluate newly developed, targeted antidepressants.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;27(3):319-28.
-
2002: Bowden Charles L
Diagnosis of bipolar disorders: focus on bipolar disorder I and bipolar disorder II.
MedGenMed : Medscape general medicine 2002;4(3):17.
-
2002: Grunze Heinz; Kasper Siegfried; Goodwin Guy; Bowden Charles; Baldwin David; Licht Rasmus; Vieta Eduard; Möller Hans-Jürgen;
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2002;3(3):115-24.
-
2002: Sachs Gary S; Grossman Fred; Ghaemi S Nassir; Okamoto Akiko; Bowden Charles L
Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
The American journal of psychiatry 2002;159(7):1146-54.
-
2002: Suppes Trisha; Dennehy Ellen B; Swann Alan C; Bowden Charles L; Calabrese Joseph R; Hirschfeld Robert M A; Keck Paul E; Sachs Gary S; Crismon M Lynn; Toprac Marcia G; Shon Steven P;
Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000.
The Journal of clinical psychiatry 2002;63(4):288-99.
-
2002: Swann Alan C; Bowden Charles L; Calabrese Joseph R; Dilsaver Steven C; Morris David D
Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(4):530-6.
-
2002: Charney Dennis S; Nemeroff Charles B; Lewis Lydia; Laden Sally K; Gorman Jack M; Laska Eugene M; Borenstein Michael; Bowden Charles L; Caplan Arthur; Emslie Graham J; Evans Dwight L; Geller Barbara; Grabowski Lenore E; Herson Jay; Kalin Ned H; Keck Paul E; Kirsch Irving; Krishnan K Ranga R; Kupfer David J; Makuch Robert W; Miller Franklin G; Pardes Herbert; Post Robert; Reynolds Mildred M; Roberts Laura; Rosenbaum Jerrold F; Rosenstein Donald L; Rubinow David R; Rush A John; Ryan Neal D; Sachs Gary S; Schatzberg Alan F; Solomon Susan;
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders.
Archives of general psychiatry 2002;59(3):262-70.
-
2002: Tohen Mauricio; Chengappa K N Roy; Suppes Trisha; Zarate Carlos A; Calabrese Joseph R; Bowden Charles L; Sachs Gary S; Kupfer David J; Baker Robert W; Risser Richard C; Keeter Elisabeth L; Feldman Peter D; Tollefson Gary D; Breier Alan
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
Archives of general psychiatry 2002;59(1):62-9.
-
2001: Bowden C L
Clinical correlates of therapeutic response in bipolar disorder.
Journal of affective disorders 2001;67(1-3):257-65.
-
2001: Swann A C; Janicak P L; Calabrese J R; Bowden C L; Dilsaver S C; Morris D D; Petty F; Davis J M
Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of illness in randomized clinical trial participants.
Journal of affective disorders 2001;67(1-3):123-32.
-
2001: Bowden C L
A study about late age onset depression.
Acta psychiatrica Scandinavica 2001;103(6):409-10.
-
2001: Nemeroff C B; Evans D L; Gyulai L; Sachs G S; Bowden C L; Gergel I P; Oakes R; Pitts C D
Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.
The American journal of psychiatry 2001;158(6):906-12.
-
2001: Bowden C L
Novel treatments for bipolar disorder.
Expert opinion on investigational drugs 2001;10(4):661-71.
-
2001: Bowden C L
Strategies to reduce misdiagnosis of bipolar depression.
Psychiatric services (Washington, D.C.) 2001;52(1):51-5.
-
2001: Calabrese J R; Shelton M D; Bowden C L; Rapport D J; Suppes T; Shirley E R; Kimmel S E; Caban S J
Bipolar rapid cycling: focus on depression as its hallmark.
The Journal of clinical psychiatry 2001;62 Suppl 14():34-41.
-
2001: Bowden C L
Introduction: the role of anticonvulsants as mood stabilizers.
The Journal of clinical psychiatry 2001;62 Suppl 14():3-4.
-
2000: Bowden C L
The ability of lithium and other mood stabilizers to decrease suicide risk and prevent relapse.
Current psychiatry reports 2000;2(6):490-4.
-
2000: Calabrese J R; Suppes T; Bowden C L; Sachs G S; Swann A C; McElroy S L; Kusumakar V; Ascher J A; Earl N L; Greene P L; Monaghan E T
A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group.
The Journal of clinical psychiatry 2000;61(11):841-50.
-
2000: Bowden C L; Lecrubier Y; Bauer M; Goodwin G; Greil W; Sachs G; von Knorring L
Maintenance therapies for classic and other forms of bipolar disorder.
Journal of affective disorders 2000;59 Suppl 1():S57-S67.
-
2000: Stern S L; Votolato N A; Hatch J P; Bowden C L
The newer antidepressants.
Psychiatric services (Washington, D.C.) 2000;51(8):1051-2.
-
2000: Swann A C; Bowden C L; Calabrese J R; Dilsaver S C; Morris D D
Mania: differential effects of previous depressive and manic episodes on response to treatment.
Acta psychiatrica Scandinavica 2000;101(6):444-51.
-
2000: Bowden C L; Calabrese J R; McElroy S L; Gyulai L; Wassef A; Petty F; Pope H G; Chou J C; Keck P E; Rhodes L J; Swann A C; Hirschfeld R M; Wozniak P J
A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
Archives of general psychiatry 2000;57(5):481-9.
-
2000: Bowden C L
Efficacy of lithium in mania and maintenance therapy of bipolar disorder.
The Journal of clinical psychiatry 2000;61 Suppl 9():35-40.
-
1999: Swann A C; Petty F; Bowden C L; Dilsaver S C; Calabrese J R; Morris D D
Mania: gender, transmitter function, and response to treatment.
Psychiatry research 1999;88(1):55-61.
-
1999: Bowden C L
"A two-illness model of bipolar disorder"--by RT Joffe, LT Young, and GM MacQueen: a commentary.
Bipolar disorders 1999;1(1):31-5.
-
1999: Bowden C L; Mitchell P; Suppes T
Lamotrigine in the treatment of bipolar depression.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1999;9 Suppl 4():S113-7.
-
1999: Swann A C; Bowden C L; Calabrese J R; Dilsaver S C; Morris D D
Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania.
The American journal of psychiatry 1999;156(8):1264-6.
-
1999: Calabrese J R; Bowden C L; McElroy S L; Cookson J; Andersen J; Keck P E; Rhodes L; Bolden-Watson C; Zhou J; Ascher J A
Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder.
The American journal of psychiatry 1999;156(7):1019-23.
-
1999: Swann A C; Katz M M; Bowden C L; Berman N G; Stokes P E
Psychomotor performance and monoamine function in bipolar and unipolar affective disorders.
Biological psychiatry 1999;45(8):979-88.
-
1999: Bowden C L; Calabrese J R; McElroy S L; Rhodes L J; Keck P E; Cookson J; Anderson J; Bolden-Watson C; Ascher J; Monaghan E; Zhou J
The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder.
Biological psychiatry 1999;45(8):953-8.
-
1999: Calabrese J R; Bowden C L; Sachs G S; Ascher J A; Monaghan E; Rudd G D
A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.
The Journal of clinical psychiatry 1999;60(2):79-88.
-
1999: Meyers B S; Alexopoulos G S; Kakuma T; Tirumalasetti F; Gabriele M; Alpert S; Bowden C; Meltzer H Y
Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression.
Biological psychiatry 1999;45(4):448-52.
-
1999: Bowden C L
Introduction: the use of mood stabilizers in the treatment of psychiatric disorders.
The Journal of clinical psychiatry 1999;60 Suppl 5():3-4.
-
1998: Goodnick P J; Dominguez R A; DeVane C L; Bowden C L
Bupropion slow-release response in depression: diagnosis and biochemistry.
Biological psychiatry 1998;44(7):629-32.
-
1998: Bowden C L
New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigine.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;19(3):194-9.
-
1998: Siafaka-Kapadai A; Patiris M; Bowden C; Javors M
Incorporation of [3H]valproic acid into lipids in GT1-7 neurons.
Biochemical pharmacology 1998;56(2):207-12.
-
1998: Bowden C L
Key treatment studies of lithium in manic-depressive illness: efficacy and side effects.
The Journal of clinical psychiatry 1998;59 Suppl 6():13-9; discussion 20.
-
1997: Bowden C L; Dickson J
Mania from dexfenfluramine.
The Journal of clinical psychiatry 1997;58(12):548-9.
-
1997: Rosenbaum J F; Moroz G; Bowden C L
Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study Group.
Journal of clinical psychopharmacology 1997;17(5):390-400.
-
1997: Katz M M; Bowden C; Stokes P; Casper R; Frazer A; Koslow S H; Kocsis J; Secunda S; Swann A; Berman N
Can the effects of antidepressants be observed in the first two weeks of treatment?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;17(2):110-5.
-
1997: Swann A C; Bowden C L; Rush A J; Rhoades H; Rose R; Kobes R
Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response.
Journal of clinical psychopharmacology 1997;17(2):78-83.
-
1997: Silva J A; Tekell J L; Penny G; Bowden C L
Resolution of palinopsia with carbamazepine.
The Journal of clinical psychiatry 1997;58(1):30.
-
1997: Swann A C; Bowden C L; Morris D; Calabrese J R; Petty F; Small J; Dilsaver S C; Davis J M
Depression during mania. Treatment response to lithium or divalproex.
Archives of general psychiatry 1997;54(1):37-42.
-
1997: Bowden C L; Swann A C; Calabrese J R; McElroy S L; Morris D; Petty F; Hirschfeld R M; Gyulai L
Maintenance clinical trials in bipolar disorder: design implications of the divalproex-lithium-placebo study.
Psychopharmacology bulletin 1997;33(4):693-9.
-
1997: Maas J W; Bowden C L; Miller A L; Javors M A; Funderburg L G; Berman N; Weintraub S T
Schizophrenia, psychosis, and cerebral spinal fluid homovanillic acid concentrations.
Schizophrenia bulletin 1997;23(1):147-54.
-
1996: Tekell J L; Silva J A; Maas J A; Bowden C L; Starck T
Thioridazine-induced retinopathy.
The American journal of psychiatry 1996;153(9):1234-5.
-
1996: Bowden C L; Janicak P G; Orsulak P; Swann A C; Davis J M; Calabrese J R; Goodnick P; Small J G; Rush A J; Kimmel S E; Risch S C; Morris D D
Relation of serum valproate concentration to response in mania.
The American journal of psychiatry 1996;153(6):765-70.
-
1996: Bowden C L
Role of newer medications for bipolar disorder.
Journal of clinical psychopharmacology 1996;16(2 Suppl 1):48S-55S.
-
1996: Petty F; Rush A J; Davis J M; Calabrese J R; Kimmel S E; Kramer G L; Small J G; Miller M J; Swann A E; Orsulak P J; Blake M E; Bowden C L
Plasma GABA predicts acute response to divalproex in mania.
Biological psychiatry 1996;39(4):278-84.
-
1996: Bowden C L
Dosing strategies and time course of response to antimanic drugs.
The Journal of clinical psychiatry 1996;57 Suppl 13():4-9; discussion 10-2.
-
1995: Maas J W; Miller A L; Tekell J L; Funderburg L; Silva J A; True J; Velligan D; Berman N; Bowden C L
Clonidine plus haloperidol in the treatment of schizophrenia/psychosis.
Journal of clinical psychopharmacology 1995;15(5):361-4.
-
1995: Silva J A; Tekell J L; Leong G B; Bowden C L
Delusional misidentification of the self associated with nondominant cerebral pathology.
The Journal of clinical psychiatry 1995;56(4):171.
-
1995: Gabel S; Stadler J; Bjorn J; Schindledecker R; Bowden C L
Homovanillic acid and monoamine oxidase in sons of substance-abusing fathers: relationship to conduct disorder.
Journal of studies on alcohol 1995;56(2):135-9.
-
1995: Silva J A; Leong G B; Tekell J L; Bowden C L
Visual-perceptual disturbances in delusional misidentification.
The Israel journal of psychiatry and related sciences 1995;32(4):286-90.
-
1995: Bowden C L; McElroy S L
History of the development of valproate for treatment of bipolar disorder.
The Journal of clinical psychiatry 1995;56 Suppl 3():3-5.
-
1995: Bowden C L
Predictors of response to divalproex and lithium.
The Journal of clinical psychiatry 1995;56 Suppl 3():25-30.
-
1995: Bowden C L; Calabrese J R; Wallin B A; Swann A C; McElroy S L; Risch S C; Hirschfeld M A
Illness characteristics of patients in clinical drug studies of mania.
Psychopharmacology bulletin 1995;31(1):103-9.
-
1994: Silva J A; Leong G B; Garza-Treviño E S; Le Grand J; Oliva D; Weinstock R; Bowden C L
A cognitive model of dangerous delusional misidentification syndromes.
Journal of forensic sciences 1994;39(6):1455-67.
-
1994: Breslau N; Merikangas K; Bowden C L
Comorbidity of migraine and major affective disorders.
Neurology 1994;44(10 Suppl 7):S17-22.
-
1994: Gabel S; Stadler J; Bjorn J; Shindledecker R; Bowden C L
Monoamine oxidase and homovanillic acid in boys with predispositions to substance abuse.
Alcoholism, clinical and experimental research 1994;18(5):1137-42.
-
1994: Katz M M; Maas J W; Frazer A; Koslow S H; Bowden C L; Berman N; Swann A C; Stokes P E
Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1994;11(2):89-100.
-
1994: Casper R C; Katz M M; Bowden C L; Davis J M; Koslow S H; Hanin I
The pattern of physical symptom changes in major depressive disorder following treatment with amitriptyline or imipramine.
Journal of affective disorders 1994;31(3):151-64.
-
1994: Maas J W; Katz M M; Koslow S H; Swann A; Davis J M; Berman N; Bowden C L; Stokes P E; Landis H
Adrenomedullary function in depressed patients.
Journal of psychiatric research 1994;28(4):357-67.
-
1994: Swann A C; Stokes P E; Secunda S K; Maas J W; Bowden C L; Berman N; Koslow S H
Depressive mania versus agitated depression: biogenic amine and hypothalamic-pituitary-adrenocortical function.
Biological psychiatry 1994;35(10):803-13.
-
1994: Brannan S K; Talley B J; Bowden C L
Sertraline and isocarboxazid cause a serotonin syndrome.
Journal of clinical psychopharmacology 1994;14(2):144-5.
-
1994: Bowden C L; Brugger A M; Swann A C; Calabrese J R; Janicak P G; Petty F; Dilsaver S C; Davis J M; Rush A J; Small J G
Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.
JAMA : the journal of the American Medical Association 1994;271(12):918-24.
-
1994: Gabel S; Stadler J; Bjorn J; Shindledecker R; Bowden C L
Sensation seeking in psychiatrically disturbed youth: relationship to biochemical parameters and behavior problems.
Journal of the American Academy of Child and Adolescent Psychiatry 1994;33(1):123-9.
-
1993: Gabel S; Stadler J; Bjorn J; Shindledecker R; Bowden C
Dopamine-beta-hydroxylase in behaviorally disturbed youth. Relationship between teacher and parent ratings.
Biological psychiatry 1993;34(7):434-42.
-
1993: Bowden C L; Schatzberg A F; Rosenbaum A; Contreras S A; Samson J A; Dessain E; Sayler M
Fluoxetine and desipramine in major depressive disorder.
Journal of clinical psychopharmacology 1993;13(5):305-11.
-
1993: Miller A L; Maas J W; Contreras S; Seleshi E; True J E; Bowden C; Castiglioni J
Acute effects of neuroleptics on unmedicated schizophrenic patients and controls.
Biological psychiatry 1993;34(3):178-87.
-
1993: Swann A C; Secunda S K; Katz M M; Croughan J; Bowden C L; Koslow S H; Berman N; Stokes P E
Specificity of mixed affective states: clinical comparison of dysphoric mania and agitated depression.
Journal of affective disorders 1993;28(2):81-9.
-
1993: Maas J W; Contreras S A; Miller A L; Berman N; Bowden C L; Javors M A; Seleshi E; Weintraub S
Studies of catecholamine metabolism in schizophrenia/psychosis--I.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1993;8(2):97-109.
-
1993: Maas J W; Contreras S A; Miller A L; Berman N; Bowden C L; Javors M A; Seleshi E; Weintraub S E
Studies of catecholamine metabolism in schizophrenia/psychosis--II.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1993;8(2):111-6.
-
1993: Gabel S; Stadler J; Bjorn J; Shindledecker R; Bowden C L
Biodevelopmental aspects of conduct disorder in boys.
Child psychiatry and human development 1993;24(2):125-41.
-
1992: Swann A C; Stokes P E; Casper R; Secunda S K; Bowden C L; Berman N; Katz M M; Robins E
Hypothalamic-pituitary-adrenocortical function in mixed and pure mania.
Acta psychiatrica Scandinavica 1992;85(4):270-4.
-
1992: Potter W Z; Bowden C L
Valproate and mood disorders: perspectives. Introduction.
Journal of clinical psychopharmacology 1992;12(1 Suppl):2S-6S.
-
1992: Bowden C L
Psychopharmacological treatment of panic disorder.
Bulletin of the Menninger Clinic 1992;56(2 Suppl A):A29-41.
-
1992: Schildkraut J J; Schatzberg A F; Samson J A; Rosenbaum A; Bowden C L
Norepinephrine output and metabolism in depressed patients during antidepressant treatments.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():323A-324A.
-
1992: Bowden C L
Implications of psychopharmacological studies for the practice of psychoanalysis.
The Journal of the American Academy of Psychoanalysis 1992;20(3):477-86.
-
1991: Katz M M; Koslow S H; Maas J W; Frazer A; Kocsis J; Secunda S; Bowden C L; Casper R C
Identifying the specific clinical actions of amitriptyline: interrelationships of behaviour, affect and plasma levels in depression.
Psychological medicine 1991;21(3):599-611.
-
1991: Swann A C; Secunda S K; Koslow S H; Katz M M; Bowden C L; Maas J W; Davis J M; Robins E
Mania: sympathoadrenal function and clinical state.
Psychiatry research 1991;37(2):195-205.
-
1990: Javors M A; Liu M; Cuvelier B S; Bowden C L
Characterization of the effect of the adenosine agonist cyclohexyladenosine on platelet activating factor-induced increases in [Ca2+]i in human platelets in vitro.
Cell calcium 1990;11(10):647-53.
-
1990: Bowden C L
Clinical management of anxiety.
Hospital practice (Office ed.) 1990;25 Suppl 2():19-27; discussion 28-30.
-
1990: Kocsis J H; Croughan J L; Katz M M; Butler T P; Secunda S; Bowden C L; Davis J M
Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression.
The American journal of psychiatry 1990;147(5):621-4.
-
1990: Tan C H; Javors M A; Seleshi E; Lowrimore P A; Bowden C L
Effects of lithium on platelet ionic intracellular calcium concentration in patients with bipolar (manic-depressive) disorder and healthy controls.
Life sciences 1990;46(16):1175-80.
-
1989: Bowden C L; Seleshi E; Javors M A
Mania associated with high percentage of inhibition of monoamine oxidase.
The American journal of psychiatry 1989;146(1):121.
-
1989: Javors M A; Bembenek M E; Bowden C L; Abell C W; Maas J W
The effect of debrisoquin on MAO A and MAO B activities.
Life sciences 1989;45(24):2359-64.
-
1988: Contreras S A; Maas J W; Seleshi E; Bowden C L
Urine and plasma levels of dopamine metabolites in response to apomorphine and neuroleptics in schizophrenics.
Biological psychiatry 1988;24(7):818-22.
-
1988: Bowden C L; Miller A L; Seleshi E
New developments in the treatment of anxiety disorders.
Texas medicine 1988;84(9):38-42.
-
1988: Davis J M; Koslow S H; Gibbons R D; Maas J W; Bowden C L; Casper R; Hanin I; Javaid J I; Chang S S; Stokes P E
Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls.
Archives of general psychiatry 1988;45(8):705-17.
-
1988: Maas J W; Contreras S A; Seleshi E; Bowden C L
Dopamine metabolism and disposition in schizophrenic patients. Studies using debrisoquin.
Archives of general psychiatry 1988;45(6):553-9.
-
1988: Bowden C L; Deutsch C K; Swanson J M
Plasma dopamine-beta-hydroxylase and platelet monoamine oxidase in attention deficit disorder and conduct disorder.
Journal of the American Academy of Child and Adolescent Psychiatry 1988;27(2):171-4.
-
1988: Bowden C L; Huang L G; Javors M A; Johnson J M; Seleshi E; McIntyre K; Contreras S; Maas J W
Calcium function in affective disorders and healthy controls.
Biological psychiatry 1988;23(4):367-76.
-
1987: Contreras S A; Maas J W; Seleshi E; Bowden C L
Increase in human urine homovanillic acid concentration after neuroleptic treatment is the same with or without debrisoquin administration.
Archives of general psychiatry 1987;44(12):1109-10.
-
1987: Mohl P C; Huang L; Bowden C; Fischbach M; Vogtsberger K; Talal N
Natural killer cell activity in major depression.
The American journal of psychiatry 1987;144(12):1619.
-
1987: Katz M M; Koslow S H; Maas J W; Frazer A; Bowden C L; Casper R; Croughan J; Kocsis J; Redmond E
The timing, specificity and clinical prediction of tricyclic drug effects in depression.
Psychological medicine 1987;17(2):297-309.
-
1987: Contreras S; Alexander H; Faber R; Bowden C
Neuroleptic radioreceptor activity and clinical outcome in schizophrenia.
Journal of clinical psychopharmacology 1987;7(2):95-8.
-
1987: Maas J W; Koslow S H; Davis J; Katz M; Frazer A; Bowden C L; Berman N; Gibbons R; Stokes P; Landis D H
Catecholamine metabolism and disposition in healthy and depressed subjects.
Archives of general psychiatry 1987;44(4):337-44.
-
1987: Sommi R W; Crismon M L; Bowden C L
Fluoxetine: a serotonin-specific, second-generation antidepressant.
Pharmacotherapy 1987;7(1):1-15.
-
1987: Javors M; Blaisdell G; Lee J; Bowden C
Binding of imipramine to platelet membranes is lower in alcoholics than in controls.
Alcohol and drug research 1987;7(5-6):453-9.
-
1987: Javors M A; Bowden C L
The human platelet as a model for calcium metabolism in central nerve endings in the study of alcoholism.
Alcohol and drug research 1987;7(5-6):311-9.
-
1987: Bowden C L; Koslow S; Maas J W; Davis J; Garver D L; Hanin I
Changes in urinary catecholamines and their metabolites in depressed patients treated with amitriptyline or imipramine.
Journal of psychiatric research 1987;21(2):111-28.
-
1986: Houston J P; Maas J W; Bowden C L; Contreras S A; McIntyre K L; Javors M A
Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia.
Psychiatry research 1986;19(3):207-14.
-
1986: Koslow S H; Maas J W; Bowden C L; Davis J M; Hanin I; Javaid J
Tricyclic antidepressant washout effects on cerebrospinal fluid and urinary monoamine and metabolites.
Archives of general psychiatry 1986;43(10):1012-3.
-
1986: Russell I J; Vipraio G A; Morgan W W; Bowden C L
Is there a metabolic basis for the fibrositis syndrome?
The American journal of medicine 1986;81(3A):50-4.
-
1986: Gibbons R D; Maas J W; Davis J M; Swann A C; Redmond D E; Casper R C; Hanin I; Bowden C L; Kocsis J; Stokes P E
Path analysis of psychopharmacological data: catecholamine breakdown in man.
Psychiatry research 1986;18(1):89-105.
-
1986: Cohn J B; Bowden C L; Fisher J G; Rodos J J
Double-blind comparison of buspirone and clorazepate in anxious outpatients.
The American journal of medicine 1986;80(3B):10-6.
-
1986: Kocsis J H; Hanin I; Bowden C; Brunswick D
Imipramine and amitriptyline plasma concentrations and clinical response in major depression.
The British journal of psychiatry : the journal of mental science 1986;148():52-7.
-
1985: Bowden C L
Current treatment of depression.
Hospital & community psychiatry 1985;36(11):1192-200.
-
1985: Miller A L; Bowden C L; Plewes J
Lithium and impairment of renal concentrating ability.
Journal of affective disorders 1985;9(2):115-9.
-
1985: Hanin I; Koslow S H; Kocsis J H; Bowden C L; Brunswick D; Frazer A; Carl J; Robins E
Cerebrospinal fluid levels of amitriptyline, nortriptyline, imipramine and desmethylimipramine. Relationship to plasma levels and treatment outcome.
Journal of affective disorders 1985;9(1):69-78.
-
1985: Maas J W; Contreras S A; Bowden C L; Weintraub S E
Effects of debrisoquin on CSF and plasma HVA concentrations in man.
Life sciences 1985;36(22):2163-70.
-
1985: Javors M A; Houston J P; Bowden C L
EGTA-extractable calmodulin in platelet membrane is lower in alcoholics than in controls.
Alcohol (Fayetteville, N.Y.) 1985;2(3):433-6.
-
1985: Jann M W; Ereshefsky L; Saklad S R; Seidel D R; Davis C M; Burch N R; Bowden C L
Effects of carbamazepine on plasma haloperidol levels.
Journal of clinical psychopharmacology 1985;5(2):106-9.
-
1985: Bowden C L; Koslow S H; Hanin I; Maas J W; Davis J M; Robins E
Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid.
Clinical pharmacology and therapeutics 1985;37(3):316-24.
-
1984: Huang L G; Bowden C L
Platelet monoamine oxidase response to lithium treatment in psychiatric patients.
Journal of clinical psychopharmacology 1984;4(6):326-31.
-
1984: Javors M A; Bowden C L; Maas J W
3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
Journal of chromatography 1984;336(2):259-69.
-
1984: Maas J W; Koslow S H; Katz M M; Bowden C L; Gibbons R L; Stokes P E; Robins E; Davis J M
Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs.
The American journal of psychiatry 1984;141(10):1159-71.
-
1984: Bowden C L
Tranylcypromine and inhibition of MAO activity.
Journal of clinical psychopharmacology 1984;4(3):172-3.
-
1983: Bowden C L; Sledge W H; Humphrey F J; Kromer M
Educational objectives in psychiatric residency training: a survey of training directors and residents.
The American journal of psychiatry 1983;140(10):1352-5.
-
1983: Koslow S H; Maas J W; Bowden C L; Davis J M; Hanin I; Javaid J
CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis.
Archives of general psychiatry 1983;40(9):999-1010.
-
1983: Frazer A; Ramsey T A; Swann A; Bowden C; Brunswick D; Garver D; Secunda S
Plasma and erythrocyte electrolytes in affective disorders.
Journal of affective disorders 1983;5(2):103-13.
-
1982: Javors M A; Bowden C L; Ross D H
Kinetic characterization and substrate requirement for the Ca2+ uptake system in platelet membrane.
Biochimica et biophysica acta 1982;691(2):220-6.
-
1982: Bowden C L; Fisher J G
Relationship of diazepam serum level to antianxiety effects.
Journal of clinical psychopharmacology 1982;2(2):110-4.
-
1982: Maas J W; Kocsis J H; Bowden C L; Davis J M; Redmond D E; Hanin I; Robins E
Pre-treatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment.
Psychological medicine 1982;12(1):37-43.
-
1982: Bowden C L; Houston J P; Shulman R S; Clothier J M
Clinical utility of salivary lithium concentration.
International pharmacopsychiatry 1982;17(2):104-13.
-
1982: Lehmann L S; Bowden C L; Redmond F C; Stanton B C
Amitriptyline and nortriptyline response profiles in unipolar depressed patients.
Psychopharmacology 1982;77(2):193-7.
-
1981: Javors M A; Bowden C L; Ross D H
Kinetic characterization of Ca2+ transport in synaptic membranes.
Journal of neurochemistry 1981;37(2):381-7.
-
1981: Bowden C L; Redmond D E; Swann A; Maas J W
Pretreatment amine neurotransmitter system interrelationships in depression [proceedings]
Psychopharmacology bulletin 1981;17(1):70-2.
-
1980: Bowden C L; Fisher J G
Safety and efficacy of long-term diazepam therapy.
Southern medical journal 1980;73(12):1581-4.
-
1980: Maas J W; Koslow S H; Davis J M; Katz M M; Mendels J; Robins E; Stokes P E; Bowden C L
Biological component of the NIMH clinical research branch collaborative program on the psychobiology of depression: I. Background and theoretical considerations.
Psychological medicine 1980;10(4):759-76.
-
1980: Bowden C L; Humphrey F J; Thompson M G
Priorities in psychiatric residency training.
The American journal of psychiatry 1980;137(10):1243-6.
-
1980: Bowden C L; Schoenfeld L S; Adams R L
Mental health attitudes and treatment expectations as treatment variables.
Journal of clinical psychology 1980;36(3):653-7.
-
1980: Bowden C L; Sarabia F
Diagnosing manic-depressive illness in adolescents.
Comprehensive psychiatry 1980;21(4):263-9.
-
1980: Sarabia F; Bowden C L
Computerized tomographic evidence of cerebral atrophy in heavy drinkers.
Southern medical journal 1980;73(6):716-8.
-
1980: Bowden C L; Schoenfeld L S; Adams R L
A correlation between dropout status and improvement in a psychiatric clinic.
Hospital & community psychiatry 1980;31(3):192-5.
-
1979: Barnhart C C; Bowden C L
Toxic psychosis with cimetidine.
The American journal of psychiatry 1979;136(5):725-6.
-
1979: Bowden C L
Recent advances in the benzodiazepines.
Texas medicine 1979;75(1):51-4.
-
1978: Bowden C L; Maddux J F; Esquivel M
Arrests before and during methadone maintenance.
The International journal of the addictions 1978;13(6):921-31.
-
1978: Bowden C L
Lithium-responsive depression.
Comprehensive psychiatry 1978;19(3):227-31.
-
1977: Bowden C L; Giffen M B
Psychotropics and glaucoma.
The American journal of psychiatry 1977;134(11):1314.
-
1977: Bowden C L
The function and organization of NIMH.
The American journal of psychiatry 1977;134(8):939-40.
-
1976: Bowden C L; Maddux J F; Esquivel M
Methadone dispensing by community pharmacies.
The American journal of drug and alcohol abuse 1976;3(2):243-54.
-
1975: Bowden C L; Martin H W
A course on behavioral skills and the psychological aspects of dentistry.
Journal of dental education 1975;39(9):617-21.
-
1975: Bowden C L; Barton D
Goals of medical student psychiatric education.
Journal of medical education 1975;50(3):257-63.
-
1975: Bowden C L
Managing depression in the '70s.
Southern medical journal 1975;68(2):177-83.
-
1973: Bowden C L; Vordenbaumen T L; Rubin M
Methadone maintenance in community pharmacies.
Journal of the American Pharmaceutical Association 1973;13(12):684-6 passim.
-
1973: Rosenthal S H; Bowden C L
A double-blind comparison of thioridazine (Mellaril) versus diazepam (valium) in patients with chronic mixed anxiety and depressive symptoms.
Current therapeutic research, clinical and experimental 1973;15(5):261-7.
-
1972: Maddux J F; Bowden C L
Critique of success with methadone maintenance.
The American journal of psychiatry 1972;129(4):440-6.
-
1972: Bowden C L; Maddux J F
Methadone maintenance: myth and reality.
The American journal of psychiatry 1972;129(4):435-40.
-
1972: Bowden C L; Endicott J; Spitzer R L
A-B therapist variable and psychotherapeutic outcome.
The Journal of nervous and mental disease 1972;154(4):276-90.
-
1972: Bowden C L; Reeb A E
Community psychiatry: Scott County evaluation.
The Journal of the Kentucky Medical Association 1972;70(2):106-8.
-
1972: Bowden C L; Langenauer B J
Success and failure in the NARA addiction program.
The American journal of psychiatry 1972;128(7):853-6.
-
1971: Bowden C L; Bowden V M
A survey of information sources used by psychiatrists.
Bulletin of the Medical Library Association 1971;59(4):603-8.
-
1971: Langenauer B J; Bowden C L
A follow-up study of narcotic addicts in the NARA program.
The American journal of psychiatry 1971;128(1):41-6.
-
1971: Bowden C L
Determinants of initial use of opioids.
Comprehensive psychiatry 1971;12(2):136-40.
Sign-in to see more